Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Purple Biotech Ltd. ADR | 5 | 0 | 0 | 0 | €0.51 | €9.21 | 1723.168% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.63 | €3.70 | 126.994% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €120.80 | €124.93 | 3.418% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.68 | €4.00 | 49.254% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
| Abbott Laboratories | 16 | 0 | 0 | 0 | €97.22 | €116.81 | 20.148% |
| UCB S.A. | 2 | 0 | 0 | 0 | €123.05 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.50 | €35.99 | 26.264% |
| GSK plc | 1 | 0 | 0 | 0 | €20.87 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.48 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €120.00 | €109.00 | -9.167% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.28 | - | - |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.098 | - | - |
| Codexis Inc. | 5 | 2 | 0 | 0 | €3.23 | €8.36 | 158.996% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| PTC Therapeutics Inc. | 13 | 5 | 0 | 0 | €28.20 | €41.81 | 48.277% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €31.00 | €38.99 | 25.770% |
| Cara Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.67 | €4.63 | 595.090% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 0 | 0 | €38.00 | €84.74 | 123.011% |
| Akebia Therapeutics Inc. | 8 | 2 | 0 | 0 | €1.12 | €3.64 | 225.684% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.50 | - | - |
| Affimed N.V. | 8 | 6 | 0 | 0 | €0.55 | €6.54 | 1083.165% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €124.00 | €150.00 | 20.968% |